TetraPhase Pharmaceuticals to Present at the Annual UBS Global Healthcare Conference
5/17/2013 7:21:32 AM
More...
|
TetraPhase Pharmaceuticals Reports First Quarter 2013 Financial Results
5/14/2013 8:15:12 AM
More...
|
TetraPhase Pharmaceuticals Reports First Quarter 2013 Financial Results
5/14/2013 7:36:39 AM
More...
|
TetraPhase Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference
4/25/2013 9:02:52 AM
More...
|
TetraPhase Pharmaceuticals, Enanta Pharmaceuticals, Inc. Prepare for IPOs
3/19/2013 8:39:44 AM
More...
|
TetraPhase Pharmaceuticals Files for a $86 Million IPO
2/13/2013 8:57:42 AM
More...
|
TetraPhase Pharmaceuticals to Present at Three Upcoming Conferences
9/13/2012 10:05:44 AM
More...
|
TetraPhase Pharmaceuticals Announces Positive Phase 2 Data for Eravacycline (TP-434) in Patients With Complicated Intra-Abdominal Infections (cIAIs)
9/12/2012 10:12:51 AM
More...
|
TetraPhase Pharmaceuticals to Present New Clinical and Preclinical Research on Its Antibiotic Portfolio at ICAAC
9/5/2012 10:07:56 AM
More...
|
TetraPhase Pharmaceuticals to Present at Stifel Nicolaus 2012 Healthcare Conference
8/30/2012 10:00:54 AM
More...
|
|